Published in Circulation on September 09, 2014
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circ Res (2016) 0.92
Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction. Circ Heart Fail (2015) 0.89
Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation. Stem Cells (2015) 0.85
Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells. J Biol Chem (2016) 0.82
Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair. J Am Heart Assoc (2015) 0.82
Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China. PLoS One (2015) 0.79
The impact of patient co-morbidities on the regenerative capacity of cardiac explant-derived stem cells. Stem Cell Res Ther (2016) 0.78
Methylglyoxal-Induced Endothelial Cell Loss and Inflammation Contribute to the Development of Diabetic Cardiomyopathy. Diabetes (2016) 0.78
Vascular repair strategies in type 2 diabetes: novel insights. Cardiovasc Diagn Ther (2015) 0.77
Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe? J Physiol (2016) 0.76
Isolation of human explant derived cardiac stem cells from cryopreserved heart tissue. PLoS One (2017) 0.75
High Glucose Causes Human Cardiac Progenitor Cell Dysfunction by Promoting Mitochondrial Fission: Role of a GLUT1 Blocker. Biomol Ther (Seoul) (2016) 0.75
Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia. Theranostics (2017) 0.75